According to ANI Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.48 B. In 2022 the company made a revenue of $0.31 B an increase over the years 2021 revenue that were of $0.21 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.48 B | 53.87% |
2022 | $0.31 B | 46.38% |
2021 | $0.21 B | 3.67% |
2020 | $0.20 B | 0.93% |
2019 | $0.20 B | 2.47% |
2018 | $0.20 B | 13.99% |
2017 | $0.17 B | 37.49% |
2016 | $0.12 B | 68.53% |
2015 | $76.32 M | 36.36% |
2014 | $55.97 M | 126.92% |
2013 | $24.66 M | 972.06% |
2012 | $2.3 M | 428.71% |
2011 | $0.43 M | -82.41% |
2010 | $2.47 M | 96.67% |
2009 | $1.25 M | -66.57% |
2008 | $3.76 M | 663.29% |
2007 | $0.49 M | -96.59% |
2006 | $14.43 M | 5488.78% |
2005 | $0.25 M | 231.7% |
2004 | $0.07 M | |
2001 | $1.79 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $51.01 B | 10,378.70% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 11,916.24% | ๐บ๐ธ USA |
Cardinal Health CAH | $216.14 B | 44,300.35% | ๐บ๐ธ USA |
Jazz Pharmaceuticals JAZZ | $3.83 B | 687.61% | ๐ฎ๐ช Ireland |
Evoke Pharma
EVOK | $5.18 M | -98.94% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $6.88 M | -98.59% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | 3,155.03% | ๐ฎ๐ฑ Israel |
Royalty Pharma RPRX | $2.35 B | 383.66% | ๐ฌ๐ง UK |
Lannett Company LCI | $0.31 B | -36.18% | ๐บ๐ธ USA |